{
    "2019-07-15": [
        [
            {
                "time": "2023-10-01",
                "original_text": "宝树集团(01761.HK)拟向小星医生增资400万元",
                "features": {
                    "keywords": [
                        "宝树集团",
                        "小星医生",
                        "增资"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "复星医药：制剂五车间符合美国FDA cGMP标准",
                "features": {
                    "keywords": [
                        "复星医药",
                        "FDA",
                        "cGMP标准"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "复星医药：控股子公司生产线通过美国FDA现场检查",
                "features": {
                    "keywords": [
                        "复星医药",
                        "FDA",
                        "现场检查"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "科创板拆分上市，有哪些潜在投资机会？",
                "features": {
                    "keywords": [
                        "科创板",
                        "拆分上市",
                        "投资机会"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "医疗保健：短期布局中报业绩确定性高的细分龙头荐5股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "中报业绩",
                        "细分龙头"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "恒指低开高走收涨约0.3%，安踏无惧浑水第四轮打击",
                "features": {
                    "keywords": [
                        "恒指",
                        "低开高走",
                        "安踏",
                        "浑水"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "午市前瞻：香港投资气氛向淡港股短期二万九有阻力",
                "features": {
                    "keywords": [
                        "香港投资",
                        "气氛向淡",
                        "港股阻力"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "石药、中生制药和石四药领药品股普涨 4+7药品采购座谈会纪要透露利好",
                "features": {
                    "keywords": [
                        "石药",
                        "中生制药",
                        "石四药",
                        "4+7药品采购",
                        "利好"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "中信建投医药|行业周报：药品集采政策底出现，优选受压低估价值品种",
                "features": {
                    "keywords": [
                        "中信建投",
                        "药品集采",
                        "政策底",
                        "低估价值"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "港股V型反弹 三大指数由绿翻红",
                "features": {
                    "keywords": [
                        "港股",
                        "V型反弹",
                        "三大指数"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "2018医药工业百强名单揭晓，这些药企入围前十",
                "features": {
                    "keywords": [
                        "医药工业",
                        "百强名单",
                        "药企"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "内地第二轮仿制药将全国招标多只药股持续逆势上升",
                "features": {
                    "keywords": [
                        "仿制药",
                        "全国招标",
                        "药股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "复星医药市场费一年激增25亿 利润结构失衡5年投资收益105亿超净利七成",
                "features": {
                    "keywords": [
                        "复星医药",
                        "市场费",
                        "利润结构",
                        "投资收益"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}